Back to Search
Start Over
Corrigendum to "Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18": [ESMO Open 8 (2023) 101588].
- Source :
-
ESMO open [ESMO Open] 2024 Nov; Vol. 9 (11), pp. 103708. Date of Electronic Publication: 2024 Oct 18. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 2059-7029
- Volume :
- 9
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- ESMO open
- Accession number :
- 39617532
- Full Text :
- https://doi.org/10.1016/j.esmoop.2024.103708